熱門資訊> 正文
MyMD Pharma宣布将品牌更名为TNFPharmaceuticals
2024-07-22 22:52
- TNF Pharmaceuticals, formerly MyMD Pharmaceuticals, on Monday announced a rebranding to the new name “TNF Pharmaceuticals,” effective today.
- The company said it plans mid-stage clinical trials of TNF-alpha inhibitor drug MYMD-1 following statistically significant Phase 2 studies.
- The company added that it will begin trading on Nasdaq under the new trading symbol "TNFA" effective July 24, 2024.
- Press release.
More on MyMD Pharmaceuticals
- Financial information for MyMD Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
